Bookmark

Add to MyYahoo RSS

Bristol-Myers Squibb News

News on Bristol-Myers Squibb continually updated from thousands of sources around the net.

14 hrs ago | West Australian

AstraZeneca raises earnings outlook as sales climb

British-Swedish drugmaker AstraZeneca, which fought off a takeover from Pfizer earlier this year, raised its 2014 earnings outlook on Thursday and posted rising second-quarter sales.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Pharmaceuticals, Healthcare Industry

Wed Jul 30, 2014

GuruFocus.com

Vanguard Health Care Fund's Top Second Quarter Stocks

Over the duration of the second quarter the Vanguard Health Care Fund purchased added four new stocks to its holdings.

Comment?

Related Topix: Financial Markets, Biotech, Merck , Medicine, Healthcare Industry, Bloomsbury Publishing, Bristol Myers Squibb, Publishing, Media, Pharmaceuticals

The Daily Caller

Selena Gomez Shows Off Skin In Snakeskin Halter Top

The movie, which has the same producer as the 1999 classic "Ten Things I Hate About You," premieres Aug. 1. Meanwhile, Justin Bieber was getting swung on by Orlando Bloom .

Comment?

Related Topix: Charitable Organizations, American Cancer Society, Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Pharmaceuticals, Healthcare Industry

Tue Jul 29, 2014

Pharmaceutical Processing

European Commission Approves Eliquis for the Treatment of Deep Vein Thrombosis and Pulmonary Embolism

Bristol-Myers Squibb and Pfizer announced that the European Commission has approved Eliquis for the treatment of DVT and PE, and the prevention of recurrent DVT and PE in adults.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Pharmaceuticals, Healthcare Industry, Pfizer

Mon Jul 28, 2014

Pharmaceutical Technology

Bristol-Myers Squibb and Ono Pharmaceutical Collaborate on Immunotherapies

Bristol-Myers Squibb and Ono Pharmaceutical signed a collaboration agreement to jointly develop and commercialize multiple immunotherapies as single agents and combination regimens to help address the unmet medical needs of patients with cancer in Japan, South Korea, and Taiwan.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Pharmaceuticals, Healthcare Industry, Health, Lung Cancer

Fri Jul 25, 2014

BioSpace

Bristol-Myers Squibb Company Taps Bay Area's Redwood City For...

Bristol-Myers Squibb Company Taps Bay Area's Redwood City For Expansion, Pharma Giant To Increase Workforce July 25, 2014 By Renee Morad , BioSpace.com Breaking News Staff Bristol-Myers Squibb Co.

Comment?

Related Topix: Bristol Myers Squibb, Biotech, Medicine, Healthcare Industry, San Mateo County, CA, Redwood City, CA, Startups, BioSpace.com, Bloomsbury Publishing, Publishing, Media, Pharmaceuticals

Thu Jul 24, 2014

BioSpace

Bristol-Myers Squibb Company Appoints As India Country Head

Bristol-Myers Squibb India appointed Jitendra Tyagi as the BMS India country head.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex, Pharmaceuticals

Wed Jul 23, 2014

Customer Interaction Solutions

Bristol-Myers Squibb and Ono Pharmaceutical Co., Ltd. Announce...

Ono Pharmaceutical Co., Ltd. have signed a strategic collaboration agreement to jointly develop and commercialize multiple immunotherapies as single agents and combination regimens to help address the unmet medical needs of patients with cancer in Japan, South Korea and Taiwan.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Pharmaceuticals, Healthcare Industry, Health, Lung Cancer

The Motley Fool

Earnings Preview: Bristol-Myers Squibb and Celgene Corporation

Most health care stocks have been experiencing a roller coaster ride so far this year.

Comment?

Related Topix: Bloomsbury Publishing, Bristol Myers Squibb, Publishing, Media, Medarex, Pharmaceuticals, Biotech, Celgene, Medicine, Healthcare Industry

Forbes.com

Forbes Earnings Preview: Bristol Myers Squibb

Bristol Myers Squibb reports its second-quarter earnings on Thursday, July 24, 2014, and the consensus earnings per share estimate is 45 cents per share.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Pharmaceuticals, Healthcare Industry, Financial Markets

Thu Jul 10, 2014

The Motley Fool

Top Biotech Stocks to Watch Today: Allergan, Arena Pharmaceuticals and Bristol-Myers Squibb

Let's take a look at today's top stories in biotech and health care. Keep an eye out for Allergan .

Comment?

Related Topix: Bloomsbury Publishing, Bristol Myers Squibb, Publishing, Media, Medarex, Pharmaceuticals, Allergan, Biotech

Pharmaceutical Processing

Bristol-Myers Squibb Makes Plans to Submit Biologics License Application for OpdivoA

Bristol-Myers Squibb Company today announced that, following discussions with the U.S. Food and Drug Administration , the company is planning a third quarter submission of a Biologics Licensing Application for OpdivoA for previously treated advanced melanoma.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex, Pharmaceuticals, Healthcare Law, Law

Tue Jul 08, 2014

AmericanBankingNews.com

Bristol-Myers Squibb Given New $55.00 Price Target at Leerink Swann

Leerink Swann's price objective would suggest a potential upside of 14.92% from the stock's previous close.

Comment?

Related Topix: Bristol Myers Squibb, Biotech, Medicine, Healthcare Industry, Bloomsbury Publishing, Media, Publishing, Medarex, Pharmaceuticals

Mon Jul 07, 2014

Information Technology

Japan Approves First All-Oral, Interferon- and Ribavirin-Free...

Bristol-Myers Squibb Company announced today that the Japanese Ministry of Health, Labor and Welfare has approved Daklinza , a potent, pan-genotypic NS5A replication complex inhibitor , and Sunvepra , a NS3/4A protease inhibitor, providing a new treatment that can lead to cure for many patients in Japan who currently have no treatment options.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex, Hepatitis, Health, Pharmaceuticals

Health Data Management

Duke, Bristol-Myers Squibb Open Up Study Data

These areas, it says, will refine ICD-10 plans to minimize impacts on productivity and reimbursement.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Pharmaceuticals, Healthcare Industry

Thu Jul 03, 2014

Seeking Alpha

Bristol-Myers Squibb May Be Fast-Tracking Its Promising Cancer Drug

However, with the recent release of promising data and the early termination of the first batch of Phase 3 trials, the drug may hit the market sooner than expected.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Pharmaceuticals, Healthcare Industry, Oncology

Wed Jul 02, 2014

In-PharmaTechnologist.com

B-MS recalls CMO made injectable blood thinner after finding "visible particles"

Bristol Myers Squibb has recalled several batches of the injectable version of the blood thinner Coumadin made by its CMO, Pharmalucence.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Pharmaceuticals, Healthcare Industry, Bedford, MA

•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••